Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | KDM1A | O60341 | 5/20 | 0.43 |
| ▸ | SAT1 | P21673 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9227994 | 0.98 | CYP2C19 (0.50) | CYP2C19CYP1A2MEN1GLAKMT2A | |
| SCHEMBL5191406 | 0.98 | CYP2C19 (0.50) | CYP2C19CYP1A2MEN1GLAKMT2A | |
| SCHEMBL25973248 | 0.93 | — | — | |
| SCHEMBL10874428 | 0.87 | ALDH1A1 (0.41) | CYP2C19CYP1A2MEN1GLAKMT2A | |
| SCHEMBL19921563 | 0.84 | TSHR (0.59) | CYP2C19CYP1A2TSHRALDH1A1TP53 | |
| SCHEMBL27262286 | 0.84 | TSHR (0.59) | CYP2C19CYP1A2TSHRALDH1A1TP53 | |
| SCHEMBL19921564 | 0.84 | PAOX (0.47) | CYP2C19CYP1A2MEN1GLAKMT2A | |
| SCHEMBL19293338 | 0.84 | TSHR (0.52) | CYP2C19CYP1A2TSHRALDH1A1TP53 | |
| SCHEMBL12707478 | 0.84 | TSHR (0.52) | CYP2C19CYP1A2TSHRALDH1A1TP53 | |
| SCHEMBL21357680 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11851390-B2 | Reaction of glycoladehyde | TAMINCO BVBA | 2023-12-26 | — | — | US | disclosed |
| US-20210139410-A1 | REACTION OF GLYCOLADEHYDE | TAMINCO BVBA (BE) | 2021-05-13 | — | — | US | disclosed |
| EP-3774717-A1 | REACTION OF GLYCOLALDEHYDE | TAMINCO BVBA (BE) | 2021-02-17 | — | — | EP | disclosed |
| CN-111971269-A | Reaction of glycolaldehyde | 塔明克公司 | 2020-11-20 | — | — | CN | disclosed |
| EP-3290401-B1 | N-SUBSTITUTED ACYCLIC ETHYLENE DIAMINES | TAMINCO BVBA (BE) | 2020-09-23 | — | — | EP | disclosed |
| WO-2019193117-A1 | REACTION OF GLYCOLALDEHYDE | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2019-10-10 | — | — | WO | disclosed |
| EP-3290401-A1 | N-SUBSTITUTED ACYCLIC ETHYLENE DIAMINES | Taminco bvba (BE) | 2018-03-07 | — | — | EP | disclosed |
| EP-0287696-B1 | ISOQUINOLINE DERIVATIVES | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1991-01-02 | — | — | EP | disclosed |
| US-4798897-A | (AMINOALKYL)AMINOSULFONYL-SUBSTITUTED CARDIOVASCULAR AND RESPIRATORY SYSTEM DISORDERS | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1989-01-17 | — | — | US | disclosed |
| EP-0287696-A1 | Isoquinoline derivatives | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1988-10-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11851390-B2 | Reaction of glycoladehyde | ADH1A, ADH1C, GRHPR | CYP2C19 639/4885CYP1A2 341/4885MEN1 1424/4885 |
| US-20210139410-A1 | REACTION OF GLYCOLADEHYDE | ADH1A, ADH1C, GRHPR | CYP2C19 639/4885CYP1A2 341/4885MEN1 1424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.